e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
New mechanisms in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective effect of transcription factor PAX-5 (BSAP) on asthma severity
L. Sorokina, V. Mineev, M. Nyoma, V. Ivanov, V. Trofimov (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2011 - New mechanisms in airway disease
Session:
New mechanisms in airway disease
Session type:
Thematic Poster Session
Number:
712
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Sorokina, V. Mineev, M. Nyoma, V. Ivanov, V. Trofimov (Saint-Petersburg, Russian Federation). Protective effect of transcription factor PAX-5 (BSAP) on asthma severity. Eur Respir J 2011; 38: Suppl. 55, 712
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The role of transcription factor PAX-5 (BSAP) in asthma severity and in the activity of allergic inflammation
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012
Increased expression of lymphocyte transcription factor T-bet in COPD
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
A polymorphism in
DMRT1
is associated with asthma in boys only and affects promoter activity by allele-specific transcription factor binding
Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses
Year: 2012
The basic helix-loop-helix transcription factor scleraxis (Scx) is overexpressed in systemic and lung fibrosing diseases
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Common IRF1 promoter polymorphisms induce changes in transcription factor binding subsequently affecting IRF1 gene expression
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008
Expression of C/EBP transcription factors in mouse lung development
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002
Activation and localization of transcription factor, nuclear factor-κB (NF-κB), in bronchiectasis
in vivo
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001
Combinations of T-bet and HLX1 gene variants significantly increase childhood asthma risk
Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy
Year: 2008
Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
YS5: The influence of glucocorticoid therapy on trancription factor balance in asthma patients
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Transcription factor GATA-3 as a specific marker of allergic bronchial asthma
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Transcriptional factors F???3, ?-Maf, GATA3 and T-bet in different variants of bronchial asthma
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
Source: Eur Respir Rev 2009; 19: 46-54
Year: 2010
Allergic inflammatory cells use different GATA factors to activate CCR3 transcription
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Nerve growth factor (NGF) gene polymorphism in allergic asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
BR22, a 26 kDa thyroid transcription factor-1 associated protein (TAP26), is expressed in human lung cells
Source: Eur Respir J 2003; 22: 28-34
Year: 2003
The asthma-like phenotype in VIP
-/-
mice may be related to activation of transcription factor NFAT
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies
Source: Eur Respir J 2001; 18: 466-473
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept